Advertisement

Topics

MethylGene Inc. Company Profile

19:28 EST 11th December 2018 | BioPortfolio

MethylGene is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diabetes, Huntington's and inflammation. We currently have two drugs in development being tested in human clinical trials: MGCD0103 and MG98. Our strategy is to partner our programs to complement our business objectives. We have successfully partnered with MGI Pharma, Taiho Pharmaceutical, Pharmion Corporation, Merck and EnVivo Pharmaceuticals.MethylGene's experienced in-house medicinal chemistry group is able to develop drugs that specifically target enzymes that are involved in certain diseases such as cancer. We do this by understanding the characteristics of the enzyme involved in the disease and then creating a molecule that will specifically inhibit that enzyme from functioning. In this way, the enzyme may be controlled. Once we have a set of lead molecules, we have a seasoned biology team test our candidate drugs in animal models. Molecules that have the desired profile become clinical candidates and are eventually tested in human clinical trials.
The advantage of having drugs that are specific to their target is that they should only affect diseased cells leaving healthy cells untouched. This is in contrast to other approaches such as chemotherapy or radiation therapy where both healthy and diseased cells are affected causing unnecessary side effects.

Location

7220 Frederick-Banting
Montreal
Quebec
H4S 2A1
Canada

Contact

Phone: 514.337.3333
Email: info@methylgene.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

MethylGene Incorporated

MethylGene is engaged in the discovery and development of drugs for diseases for which there are currently limited or no treatments. Research on the Company's first target, the DNA Methyltransferase e...

MethylGene Inc.

MethylGene is a publicly-traded biopharmaceutical company listed on the Toronto Stock Exchange under the symbol MYG. We focus in the areas of cancer, infectious disease and other diseases such as diab...

More Information about "MethylGene Inc." on BioPortfolio

We have published hundreds of MethylGene Inc. news stories on BioPortfolio along with dozens of MethylGene Inc. Clinical Trials and PubMed Articles about MethylGene Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MethylGene Inc. Companies in our database. You can also find out about relevant MethylGene Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record